Welgene Biotech Co.,Ltd. (6661.TWO)
Taipei Exchange · TWD · Healthcare · Diagnostics & Research
NT$17.30 (+0.00%) as of
Key statistics
- Market cap
- 403.16M
- EPS (TTM)
- -0.06
- Dividend yield
- 0.00%
- 52-week range
- 15.50 – 20.35
- Beta
- 0.21
- Revenue (TTM)
- 398.92M
- Profit margin
- -0.41%
- Volume
- 2.00k
About Welgene Biotech Co.,Ltd.
Welgene Biotech Co.,Ltd. engages in the trade of biotechnology-related instruments, reagents, and biotechnology testing services. The company offers research services, including generation, PacBio third generation sequencing; microarray, protein body analysis; nucleic acid extraction/QC, single cell experimental, and bioinformatics analysis services. It also provides reagents, medical consumables, and instruments, as well as software services. Welgene Biotech Co.,Ltd. was founded in 2003 and is based in Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.